APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadolinium-Based Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gadolinium-Based Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchGadolinium-Based Contrast Agents Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadolinium-Based Contrast Agents Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Gadolinium-Based Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadolinium-Based Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadolinium-Based Contrast Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gadolinium-Based Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gadolinium-Based Contrast Agents include Agfa, BeiLu Pharma, Bracco Imaging, GE Healthcare, Guerbet Group, Hengrui Medicine, Lantheus, Marotrast and YRPG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadolinium-Based Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadolinium-Based Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadolinium-Based Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadolinium-Based Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadolinium-Based Contrast Agents Segment by Company

Agfa

BeiLu Pharma

Bracco Imaging

GE Healthcare

Guerbet Group

Hengrui Medicine

Lantheus

Marotrast

YRPG

Bayer

Jiangsu Hengrui Medicine

Stary

Gadolinium-Based Contrast Agents Segment by Type

Linear Gadolinium-Based Contrast Agents

Macrocycle Gadolinium-Based Contrast Agents

Gadolinium-Based Contrast Agents Segment by Application

Hospital

Specialist Clinic

Others

Gadolinium-Based Contrast Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-Based Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-Based Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-Based Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadolinium-Based Contrast Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gadolinium-Based Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gadolinium-Based Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gadolinium-Based Contrast Agents Industry Trends Table 2. Gadolinium-Based Contrast Agents Industry Drivers Table 3. Gadolinium-Based Contrast Agents Industry Opportunities and Challenges Table 4. Gadolinium-Based Contrast Agents Industry Restraints Table 5. Global Gadolinium-Based Contrast Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gadolinium-Based Contrast Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gadolinium-Based Contrast Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gadolinium-Based Contrast Agents Sales Market Share by Manufacturers Table 9. Global Gadolinium-Based Contrast Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gadolinium-Based Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gadolinium-Based Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gadolinium-Based Contrast Agents Manufacturers, Product Type & Application Table 13. Global Gadolinium-Based Contrast Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadolinium-Based Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Linear Gadolinium-Based Contrast Agents Table 17. Major Manufacturers of Macrocycle Gadolinium-Based Contrast Agents Table 18. Global Gadolinium-Based Contrast Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Gadolinium-Based Contrast Agents Sales by Type (2021-2026) & (K Units) Table 20. Global Gadolinium-Based Contrast Agents Sales by Type (2027-2032) & (K Units) Table 21. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2026) Table 22. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2027-2032) Table 23. Global Gadolinium-Based Contrast Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Gadolinium-Based Contrast Agents Revenue by Type (2021-2026) & (K Units) Table 25. Global Gadolinium-Based Contrast Agents Revenue by Type (2027-2032) & (K Units) Table 26. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2026) Table 27. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Specialist Clinic Table 30. Major Manufacturers of Others Table 31. Global Gadolinium-Based Contrast Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Gadolinium-Based Contrast Agents Sales by Application (2021-2026) & (K Units) Table 33. Global Gadolinium-Based Contrast Agents Sales by Application (2027-2032) & (K Units) Table 34. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2026) Table 35. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2027-2032) Table 36. Global Gadolinium-Based Contrast Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Gadolinium-Based Contrast Agents Revenue by Application (2021-2026) & (K Units) Table 38. Global Gadolinium-Based Contrast Agents Revenue by Application (2027-2032) & (K Units) Table 39. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2026) Table 40. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2027-2032) Table 41. Global Gadolinium-Based Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Gadolinium-Based Contrast Agents Sales by Region (2021-2026) & (K Units) Table 43. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2021-2026) Table 44. Global Gadolinium-Based Contrast Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Gadolinium-Based Contrast Agents Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 48. North America Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 49. Europe Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 51. Europe Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 58. Global Gadolinium-Based Contrast Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Gadolinium-Based Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Gadolinium-Based Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2021-2026) Table 62. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2027-2032) Table 63. Agfa Company Information Table 64. Agfa Business Overview Table 65. Agfa Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Agfa Gadolinium-Based Contrast Agents Product Portfolio Table 67. Agfa Recent Development Table 68. BeiLu Pharma Company Information Table 69. BeiLu Pharma Business Overview Table 70. BeiLu Pharma Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio Table 72. BeiLu Pharma Recent Development Table 73. Bracco Imaging Company Information Table 74. Bracco Imaging Business Overview Table 75. Bracco Imaging Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio Table 77. Bracco Imaging Recent Development Table 78. GE Healthcare Company Information Table 79. GE Healthcare Business Overview Table 80. GE Healthcare Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio Table 82. GE Healthcare Recent Development Table 83. Guerbet Group Company Information Table 84. Guerbet Group Business Overview Table 85. Guerbet Group Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio Table 87. Guerbet Group Recent Development Table 88. Hengrui Medicine Company Information Table 89. Hengrui Medicine Business Overview Table 90. Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 92. Hengrui Medicine Recent Development Table 93. Lantheus Company Information Table 94. Lantheus Business Overview Table 95. Lantheus Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lantheus Gadolinium-Based Contrast Agents Product Portfolio Table 97. Lantheus Recent Development Table 98. Marotrast Company Information Table 99. Marotrast Business Overview Table 100. Marotrast Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Marotrast Gadolinium-Based Contrast Agents Product Portfolio Table 102. Marotrast Recent Development Table 103. YRPG Company Information Table 104. YRPG Business Overview Table 105. YRPG Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. YRPG Gadolinium-Based Contrast Agents Product Portfolio Table 107. YRPG Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bayer Gadolinium-Based Contrast Agents Product Portfolio Table 112. Bayer Recent Development Table 113. Jiangsu Hengrui Medicine Company Information Table 114. Jiangsu Hengrui Medicine Business Overview Table 115. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 117. Jiangsu Hengrui Medicine Recent Development Table 118. Stary Company Information Table 119. Stary Business Overview Table 120. Stary Gadolinium-Based Contrast Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Stary Gadolinium-Based Contrast Agents Product Portfolio Table 122. Stary Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Gadolinium-Based Contrast Agents Distributors List Table 126. Gadolinium-Based Contrast Agents Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Gadolinium-Based Contrast Agents Product Image Figure 2. Global Gadolinium-Based Contrast Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadolinium-Based Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Gadolinium-Based Contrast Agents Sales (2021-2032) & (K Units) Figure 5. Global Gadolinium-Based Contrast Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gadolinium-Based Contrast Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Linear Gadolinium-Based Contrast Agents Image Figure 9. Macrocycle Gadolinium-Based Contrast Agents Image Figure 10. Global Gadolinium-Based Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Gadolinium-Based Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2032) Figure 13. Global Gadolinium-Based Contrast Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Gadolinium-Based Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Specialist Clinic Image Figure 18. Others Image Figure 19. Global Gadolinium-Based Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Gadolinium-Based Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2032) Figure 22. Global Gadolinium-Based Contrast Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Gadolinium-Based Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2032) Figure 25. North America Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 27. U.S. Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 32. Germany Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 39. China Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2032) Figure 47. Brazil Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Gadolinium-Based Contrast Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Gadolinium-Based Contrast Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Gadolinium-Based Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 58. North America Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Gadolinium-Based Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 60. Europe Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Gadolinium-Based Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Gadolinium-Based Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gadolinium-Based Contrast Agents Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Gadolinium-Based Contrast Agents Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Linear Gadolinium-Based Contrast Agents
  • Macrocycle Gadolinium-Based Contrast Agents
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • Agfa
  • BeiLu Pharma
  • Bracco Imaging
  • GE Healthcare
  • Guerbet Group
  • Hengrui Medicine
  • Lantheus
  • Marotrast
  • YRPG
  • Bayer
  • Jiangsu Hengrui Medicine
  • Stary

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gadolinium-Based Contrast Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gadolinium-Based Contrast Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gadolinium-Based Contrast Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gadolinium-Based Contrast Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gadolinium-Based Contrast Agents Market Dynamics
  1. 2.1 Gadolinium-Based Contrast Agents Industry Trends
  2. 2.2 Gadolinium-Based Contrast Agents Industry Drivers
  3. 2.3 Gadolinium-Based Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Gadolinium-Based Contrast Agents Industry Restraints
3 Gadolinium-Based Contrast Agents Market by Manufacturers
  1. 3.1 Global Gadolinium-Based Contrast Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gadolinium-Based Contrast Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gadolinium-Based Contrast Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gadolinium-Based Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gadolinium-Based Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gadolinium-Based Contrast Agents Manufacturers, Product Type & Application
  7. 3.7 Global Gadolinium-Based Contrast Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gadolinium-Based Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gadolinium-Based Contrast Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gadolinium-Based Contrast Agents Tier 1, Tier 2, and Tier 3
4 Gadolinium-Based Contrast Agents Market by Type
  1. 4.1 Gadolinium-Based Contrast Agents Type Introduction
  2. 4.1.1 Linear Gadolinium-Based Contrast Agents
  3. 4.1.2 Macrocycle Gadolinium-Based Contrast Agents
  4. 4.2 Global Gadolinium-Based Contrast Agents Sales by Type
  5. 4.2.1 Global Gadolinium-Based Contrast Agents Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gadolinium-Based Contrast Agents Sales by Type (2021-2032)
  7. 4.2.3 Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gadolinium-Based Contrast Agents Revenue by Type
  9. 4.3.1 Global Gadolinium-Based Contrast Agents Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2021-2032)
  11. 4.3.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2021-2032)
5 Gadolinium-Based Contrast Agents Market by Application
  1. 5.1 Gadolinium-Based Contrast Agents Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialist Clinic
  4. 5.1.3 Others
  5. 5.2 Global Gadolinium-Based Contrast Agents Sales by Application
  6. 5.2.1 Global Gadolinium-Based Contrast Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gadolinium-Based Contrast Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gadolinium-Based Contrast Agents Revenue by Application
  10. 5.3.1 Global Gadolinium-Based Contrast Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2021-2032)
6 Global Gadolinium-Based Contrast Agents Sales by Region
  1. 6.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadolinium-Based Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Gadolinium-Based Contrast Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Gadolinium-Based Contrast Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gadolinium-Based Contrast Agents Revenue by Region
  1. 7.1 Global Gadolinium-Based Contrast Agents Revenue by Region
  2. 7.1.1 Global Gadolinium-Based Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gadolinium-Based Contrast Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Gadolinium-Based Contrast Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gadolinium-Based Contrast Agents Revenue (2021-2032)
  8. 7.2.2 North America Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gadolinium-Based Contrast Agents Revenue (2021-2032)
  11. 7.3.2 Europe Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gadolinium-Based Contrast Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gadolinium-Based Contrast Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gadolinium-Based Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Agfa
  2. 8.1.1 Agfa Company Information
  3. 8.1.2 Agfa Business Overview
  4. 8.1.3 Agfa Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
  6. 8.1.5 Agfa Recent Developments
  7. 8.2 BeiLu Pharma
  8. 8.2.1 BeiLu Pharma Company Information
  9. 8.2.2 BeiLu Pharma Business Overview
  10. 8.2.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
  12. 8.2.5 BeiLu Pharma Recent Developments
  13. 8.3 Bracco Imaging
  14. 8.3.1 Bracco Imaging Company Information
  15. 8.3.2 Bracco Imaging Business Overview
  16. 8.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
  18. 8.3.5 Bracco Imaging Recent Developments
  19. 8.4 GE Healthcare
  20. 8.4.1 GE Healthcare Company Information
  21. 8.4.2 GE Healthcare Business Overview
  22. 8.4.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
  24. 8.4.5 GE Healthcare Recent Developments
  25. 8.5 Guerbet Group
  26. 8.5.1 Guerbet Group Company Information
  27. 8.5.2 Guerbet Group Business Overview
  28. 8.5.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
  30. 8.5.5 Guerbet Group Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
  37. 8.7 Lantheus
  38. 8.7.1 Lantheus Company Information
  39. 8.7.2 Lantheus Business Overview
  40. 8.7.3 Lantheus Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
  42. 8.7.5 Lantheus Recent Developments
  43. 8.8 Marotrast
  44. 8.8.1 Marotrast Company Information
  45. 8.8.2 Marotrast Business Overview
  46. 8.8.3 Marotrast Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
  48. 8.8.5 Marotrast Recent Developments
  49. 8.9 YRPG
  50. 8.9.1 YRPG Company Information
  51. 8.9.2 YRPG Business Overview
  52. 8.9.3 YRPG Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
  54. 8.9.5 YRPG Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Jiangsu Hengrui Medicine
  62. 8.11.1 Jiangsu Hengrui Medicine Company Information
  63. 8.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 8.11.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  66. 8.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 8.12 Stary
  68. 8.12.1 Stary Company Information
  69. 8.12.2 Stary Business Overview
  70. 8.12.3 Stary Gadolinium-Based Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
  72. 8.12.5 Stary Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadolinium-Based Contrast Agents Value Chain Analysis
  2. 9.1.1 Gadolinium-Based Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadolinium-Based Contrast Agents Production Mode & Process
  6. 9.2 Gadolinium-Based Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadolinium-Based Contrast Agents Distributors
  9. 9.2.3 Gadolinium-Based Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst